Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

MR antagonists may improve skin health and wound healing, especially in aging.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Neuroactive steroids and the enzyme 5α-reductase might be involved in the development of Tourette's syndrome.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Researchers made two new compounds that could be used for medicine.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

GD-23 reduces anxiety by relying on neurosteroid production.

Activating Tgr5 may help treat hair loss and bone loss.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Testosterone metabolites may help relieve diabetic nerve pain.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

5α-reductase 2 is crucial for stress response in male rats.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

A new compound may treat benign prostatic hyperplasia better than finasteride.

New drugs like N-acetylcysteine and dronabinol show promise for treating hair-pulling disorder.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.